| MDL | MFCD13152357 |
|---|---|
| Molecular Weight | 414.50 |
| Molecular Formula | C17H22N2O6S2 |
| SMILES | CC1(C)[C@H](C(NO)=O)N(S(=O)(C2=CC=C(OCC#CCO)C=C2)=O)CCS1 |
|
MMP |
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00095342 | Wyeth is now a wholly owned subsidiary of Pfizer |
Rheumatoid Arthritis
|
Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 41.4 mg/mL ( 99.88 mM ; Need ultrasonic and warming)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.4125 mL | 12.0627 mL | 24.1255 mL |
| 5 mM | 0.4825 mL | 2.4125 mL | 4.8251 mL |
| 10 mM | 0.2413 mL | 1.2063 mL | 2.4125 mL |